NUOVO PROBE was established in November 2006 in UK, company registration number 5993342, as a R&D company with focus on biomedicine. The company goal is in development of novel electromagnetic diagnostic-cure technologies from proof of concept through clinical trials to commercialisation. It plans to undertake commercialisation with established global partners.
Role & Activities of the organisation in the project
Electromagnetics of biological tissue with functionalized, complex nanoparticles for both diagnostic and cure. An assessment of an efficacy of electromagnetic (primeraly magnetic) hyperthermia
Key People involved in the project
Prof. Serguei Semenov, Co-Director of the NuovoProbe Ltd
Dr. Khue Tian Lai, Research Associate
Responsible for the optical and dielectric characterisations of NPs in suspension using electromagnetic (EM) spectroscopy methods.
Mr. Sundaramoorthy Thirunavukkarasu, Research Student
Involved in the optical and dielectric characterisations of NPs in suspension using electromagnetic (EM) spectroscopy methods.
● Semenov S “System and method for electromagnetic imaging and therapeutics using specialized nanoparticles”, USA provisional patent application, 04 October, 2010.
● K. T. Lai, S. Semenov, A. M. Piras, F. Chiellini, C. Ravagli, and G. Baldi, Optical and Dielectric Characterisations of Magnetic Nanoparticles in Suspension, 14th European Microwave Week, Manchester, UK, 09-14th October 2011.
● Semenov S., Lai K.T. “Electromagnetic imaging and magnetic hyperthermia using composite nanoparticles. An initial assessment of novel diagnostic-cure approach”, International Conference for Micro & Nanotechnologies for the BioScience – NanoBiotech 2011, Montreux, Switzerland, November 14-16, 2011.
● K.T. Lai, B. G. Nair, S. Semenov, A.M. Piras, F. Chiellini, C. Ravagli, G. Baldi “A Feasibility Study of Bioerodible Polymer Coated Ferromagnetic Nanoparticles for Biomedical Applications”, International Conference for Micro & Nanotechnologies for the BioScience – NanoBiotech 2011, Montreux, Switzerland, November 14-16, 2011.